IRCCS Azienda Ospedaliero-Universitaria di Bologna /ID# 214745

Bologna 40138

0 studies enrolling now · 1 studies all time

What they study most

Plaque Psoriasis

Studies at this site

• A Study of the Safety and Efficacy of Risankizumab in Adult Participants With Plaque Psoriasis Who Have Had a Suboptimal Response to Secukinumab or Ixekizumab — Completed